These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11250041)

  • 41. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors.
    Zhang L; van Bree S; van Rood JJ; Claas FH
    Transplantation; 1990 Dec; 50(6):1008-10. PubMed ID: 2256142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of donor-specific and non-donor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching.
    Tambur AR; Buckingham M; McDonald L; Luo X
    Clin Transpl; 2006; ():399-404. PubMed ID: 18365396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions.
    Geertsen RC; Hofbauer GF; Yue FY; Manolio S; Burg G; Dummer R
    J Invest Dermatol; 1998 Sep; 111(3):497-502. PubMed ID: 9740247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimates of cytotoxic T-lymphocyte precursor frequencies against HLA class I antigens in responder-stimulator pairs with a negative mixed lymphocyte culture reaction.
    Slavcev AS; Breur-Vriesendorp BS; Ivanyi P
    Hum Immunol; 1995 Oct; 44(2):97-102. PubMed ID: 8847234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
    Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
    Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA class I donor-specific triplet antibodies detected after renal transplantation.
    Varnavidou-Nicolaidou A; Doxiadis II; Iniotaki-Theodoraki A; Patargias T; Stavropoulos-Giokas C; Kyriakides GK
    Transplant Proc; 2004; 36(6):1732-4. PubMed ID: 15350464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.
    Chauhan B; Phelan DL; Marsh JW; Mohanakumar T
    Transplantation; 1993 Aug; 56(2):443-8. PubMed ID: 7689260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
    Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
    Oudshoorn M; Doxiadis II; van den Berg-Loonen PM; Voorter CE; Verduyn W; Claas FH
    Hum Immunol; 2002 Mar; 63(3):176-84. PubMed ID: 11872235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of antibodies to HLA class I antigens by an immunoenzyme method].
    Borozdenkova SD; Baryshnikov AIu; Palkina TN; Baranova FS
    Biull Eksp Biol Med; 1995 Sep; 120(9):315-7. PubMed ID: 8593350
    [No Abstract]   [Full Text] [Related]  

  • 52. How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402?
    Lomago J; Jelenik L; Zern D; Howe J; Martell J; Zeevi A; Duquesnoy RJ
    Hum Immunol; 2010 Feb; 71(2):176-8. PubMed ID: 19963027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens.
    Roelen DL; van Bree SP; van Beelen E; Schanz U; van Rood JJ; Claas FH
    Transplantation; 1994 Feb; 57(3):446-50. PubMed ID: 8108881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of HLA antibodies with the PRA-STAT test. An ELISA test using soluble HLA class I molecules.
    Zachary AA; Griffin J; Lucas DP; Hart JM; Leffell MS
    Transplantation; 1995 Dec; 60(12):1600-6. PubMed ID: 8545897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-HLA alloantibody is found in children but does not correlate with a lack of HIV type 1 transmission from infected mothers.
    Luscher MA; Choy G; Embree JE; Nagelkerke NJ; Bwayo JJ; Njenga S; Plummer FA; Barber BH; MacDonald KS
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):99-107. PubMed ID: 9462919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts.
    Hoekstra F; Witvliet M; Knoop C; Akkersdijk G; Jutte N; Bogers A; Claas F; Weimar W
    J Heart Lung Transplant; 1997 May; 16(5):570-2. PubMed ID: 9171278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.